DN-9693

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDN-9693
Drug Alias NameDN-9693
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsMyocardial IschemiaHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A